Phone: (914) 847-7000Website: ---s: --- regeneron com Careers: careers regeneron com 777 Old Saw Mill River Road 5 days ago · During the FDA review, the analyses were updated; the FDA - approved results at 36 weeks in the label for Dupixent compared to placebo are: 18 3% of patients experienced sustained disease remission compared to 6 1% (12 2% difference; 95% confidence interval: -0 8% to 26 1%), the primary endpoint Tarrytown, NY 10591 See full list on drugs com Search results may contain information that is not included in the approved product labeling Regeneron recommends the use of its products only for approved indications Please refer to the full prescribing information for approved product label Jan 22, 2022 · On January 24, 2022, the FDA revised the emergency use authorization for REGEN-COV due to the COVID-19 Omicron variant The FDA stopped the medication's use in any area where COVID-19 exposure or infections are likely caused by a variant that isn't treatable by REGEN-COV U S Approved Medicines Our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA - approved or authorized medicines, almost all of which were homegrown in Regeneron 's laboratories This page is intended for U S residents only Regeneron Pharmaceuticals, Inc Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines Join our team and explore clinical trials Our approved and authorized medicines are only the beginning of our long-term commitment to solve the human body’s most complex mysteries Almost 100% of our product candidates were invented and developed in-house, and Regeneron -invented medicines are available in over 100 countries worldwide